Newsy's Latest Health News

The World Health Organization (WHO) has resumed testing hydroxychloroquine as a potential COVID-19 treatment after a safety review. A Lancet study had previously raised concerns about the drug's safety, but its accuracy was questioned. Meanwhile, Roche received FDA approval for a blood test to identify COVID-19 patients at risk of severe inflammatory response and is testing its arthritis drug ACTEMRA for COVID-19-related pneumonia. These efforts are part of a broader initiative to repurpose existing drugs to combat the virus.

What is the purpose of testing the arthritis drug ACTEMRA in COVID-19 patients?

What is the significance of pharmaceutical companies repurposing existing medicines in the fight against COVID-19?